Rumor claims Apple is attempting to secure Patents & Cooperation from Suppliers to bring a Powerful Zoom Lens to Future iPhones

  In July Patently Apple posted a report titled “While a Periscope Camera Module was supposed to be ready for iPhone 11, a new Rumor claims that the Project is still ongoing.” The report looked back to a 2018 report where Apple supplier described a new 5P periscope lens for […]

 

In July Patently Apple posted a report titled “While a Periscope Camera Module was supposed to be ready for iPhone 11, a new Rumor claims that the Project is still ongoing.” The report looked back to a 2018 report where Apple supplier described a new 5P periscope lens for Apple’s 2019 iPhones. That never panned out and Huawei went on to bring this valued feature to market first.

 

Apple analyst Ming-Chi Kuo forecast during this past summer that Apple might have a powerful zoom periscope lens for 2021 iPhones using Korean supplier SEMCO.

 

Today, the rumor of Apple seeking to adopt periscope lens technology to greatly enhance zoom power has returned in a Digitimes rumor. Their snippet states that “Relevant people in the South Korean industry said that in order to enhance the optical zoom function of the iPhone, Apple is looking for folding camera technology and patents, and cooperation discussions with related companies have aroused industry attention.

 

The Digitimes byline reads: Has “Apple passed on folding camera technology or joined hands with Samsung Electronics?” Below is a Samsung video on their periscope technology.

 

 

In today’s world, consumers are primarily buying an Apple Camera that happens to be a smartphone. A periscope lens could be a killer feature for a future iPhone and one that would certainly nudge me to upgrade as soon as it’s available.

 

10.2  Supply Chain News & Rumors

Source Article

Next Post

Pfizer: A 'New' Growth Foundation In Genomic Medicine (NYSE:PFE)

Table of Contents1 Combined yield of 10%: Getting paid to wait.2 Financial recap: A look back to step forward3 Biopharma: The best of both worlds4 Rare Diseases5 Vaccines6 Genomic Medicine Next Source: Finviz “With the separation of Consumer Health last year and the expected separation of Upjohn later this year, […]

Subscribe US Now